lenalidomide has been researched along with Lymph Node Metastasis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Fang, Y; Fei, XC; Janin, A; Jiang, XF; Leboeuf, C; Li, B; Song, Q; Sun, YF; Wang, CF; Wang, L; Xu, PP; Yan, ZX; Zhao, WL; Zhao, Y | 1 |
| Burg, S; Crickx, B; Di Lucca, J; Feldman, J; Joly, V; Lariven, S; Marinho, E; Maubec, E; Peytavin, G; Raymond, E; Sarda-Mantel, L; Steff, M | 1 |
| Marschner, N; Zaiss, M | 1 |
3 other study(ies) available for lenalidomide and Lymph Node Metastasis
| Article | Year |
|---|---|
JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide.
Topics: Animals; Cell Adhesion Molecules; Cell Line, Tumor; Disease Progression; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Lenalidomide; Lymphatic Metastasis; Lymphoma, Large B-Cell, Diffuse; Male; Mice; Neoplasm Invasiveness; Nodal Protein; Prognosis; Receptors, Cell Surface; Signal Transduction; Transforming Growth Factor beta; Up-Regulation; Xenograft Model Antitumor Assays; Zebrafish | 2017 |
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma.
Topics: AIDS-Related Opportunistic Infections; Angiogenesis Inhibitors; Antiretroviral Therapy, Highly Active; Black People; CD4 Lymphocyte Count; Compassionate Use Trials; HIV-1; Humans; Lenalidomide; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Pancreatic Neoplasms; Sarcoma, Kaposi; Thalidomide; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Viral Load | 2013 |
Long-term disease stabilization in a patient with castration-resistant metastatic prostate cancer by the addition of lenalidomide to low-dose dexamethasone and celecoxib.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Castration; Celecoxib; Dexamethasone; Humans; Lenalidomide; Longitudinal Studies; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Pyrazoles; Sulfonamides; Thalidomide; Treatment Failure; Treatment Outcome | 2012 |